New Delhi, Jan 29 (IANS) Amid growing influence of artificial intelligence (AI) in healthcare, a new large-scale clinical trial published in The Lancet on Thursday showed that an AI-enabled stethoscope can boost early detection of various heart diseases.A team of Spanish researchers found that an AI-enabled stethoscope helped doctors in identifying early signs of serious heart conditions, such as heart failure, arrhythmias, and valve disease, in primary care clinics.The study found that introduc…
Latest The Lancet News & Updates
New Delhi, Jan 27 (IANS) Health experts on Tuesday urged the government to introduce tax-funded Universal Health Care, and boost resources at government hospitals in the upcoming Union Budget 2026.The experts also highlighted the lack of funds to in public health care institutions to deliver adequate services to a large number of patients and stressed the need to expand PMJAY to include outpatient care.“We advocate tax-funded Universal Health Care with a basic health package for all citizens a…
New Delhi, Jan 14 (IANS) Just five more minutes of sleep, and two minutes of moderate exercise like brisk walking or climbing stairs can add a year to your life, according to a study on Wednesday.Adding half a serving of vegetables per day more could also lead to an extra year of life for people with the worst existing sleep, physical activity, and dietary habits, revealed the study that followed 60,000 people for eight long years.The study, published in The Lancet journal eClinicalMedicine, sug…
New Delhi, Jan 13 (IANS) Women and the elderly are more likely to be vaccine-hesitant, according to a study on Tuesday, which analysed data from more than 1.1 million people.The study, published in The Lancet, analysed hesitancy based on Covid-19 vaccine uptake and found that hesitancy against vaccines was rooted in concerns about their efficacy. While it reduced over time, it persists in some people.The researchers from Imperial College London, UK, found that the likelihood of remaining unvacci…
New Delhi, Dec 23 (IANS) A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.All three doses and regimens of the vaccine named HeV-sG-V demonstrated to be safe and generated an immune response, according to the researchers in the study published in the journal The Lancet.”The induction of antibodies within 1 month of vaccination, along with the persistence afforded by two dosages, suggests the vaccine ca…